FDA approves another treatment for advanced melanoma
September 5th 2014FDA has approved pembrolizumab (Keytruda, Merck) for treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs. Pembrolizumab, which received breakthrough therapy designation for advanced melanoma, is the sixth new melanoma treatment approved since 2011.
Pharmacist connected to 2012 meningitis deaths arrested
September 5th 2014Federal agents Thursday arrested the former supervising pharmacist of New England Compounding Center in Massachusetts, which in 2012 provided tainted drugs that led to a fungal meningitis outbreak that killed 64 people and sickened more than 700.
Bill permitting pharmacists to dispense naloxone without prescription passes in California
August 20th 2014California lawmakers passed a bill that would allow pharmacists to furnish naloxone without a prescription according to guidelines yet to be established by the state’s pharmacy and medical boards.
Pharmacy professor develops naloxone nasal spray
August 20th 2014A University of Kentucky pharmacy professor has developed a quicker, easier way to deliver naloxone via a nasal spray, and his invention is being fast-tracked by the Food and Drug Administration, according to a report in the Lexington Herald-Leader.
CDC committee endorses Pfizer pneumonia vaccine
August 15th 2014A Centers for Disease Control and Prevention (CDC) committee has recommended Prevnar 13 [Pneumococcal 13-valent Conjugate Vaccine] for routine use to help protect adults aged 65 years and older against pneumococcal disease, Pfizer announced.
Need for specialty pharmacy certification grows
August 13th 2014As the field of specialty pharmacy grows and as graduates continue to enter the pharmacy profession, the need for specialty pharmacy certification will grow, said Gary Rice, RPh, MS, MBA, vice president of clinical services for Diplomat Specialty Pharmacy and immediate past president of the Specialty Pharmacy Certification Board (SPCB), during a webinar this week.
Pharmacy professionals in Sierra Leone dead following Ebola outbreak
August 13th 2014Reports received by the International Pharmaceutical Federation (FIP) specify that a pharmacist and four pharmacy technicians from the community practice setting in Sierra Leone have died as a result of the Ebola virus outbreak. Another report from Sierra Leone’s pharmacy board noted that a pharmacy technician who was working in a community pharmacy in Kenema has died.
GSK clinical trial may start this fall for Ebola vaccine
August 12th 2014GlaxoSmithKline (GSK) with its partner, the National Institute of Allergy and Infectious Diseases (NIAID), is expected to begin a phase 1 trial this fall on a potential vaccine for the treatment of Ebola virus, a deadly disease that has killed approximately 1,000 in a recent outbreak in West Africa, according to a report by Reuters.